Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.15
+0.14 (2.00%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$135,765
Profits / Employee
$5,388,000
Market Cap
28.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -191 | -84.89% |
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Enlivex | 34 |
| Tevogen | 18 |
| BriaCell Therapeutics | 16 |
| Genenta Science | 9 |
| Dyadic International | 5 |
KYNB News
- 6 days ago - Kyntra Bio Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - Kyntra Bio Earnings release: Q2 2026 - Filings
- 6 days ago - Kyntra Bio Quarterly report: Q2 2026 - Filings
- 6 days ago - Kyntra Bio Slides: Q2 2026 - Filings
- 6 days ago - Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Kyntra Bio Transcript: AGM 2026 - Transcripts
- 2 months ago - Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes - GlobeNewsWire
- 3 months ago - Kyntra Bio Earnings Call Transcript: Q1 2026 - Transcripts